Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
12/21/2000 | CA2376446A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds |
12/21/2000 | CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
12/21/2000 | CA2376372A1 A model biofilm for efficacy assessment of antimicrobials |
12/21/2000 | CA2376243A1 Gustatory receptors in drosophila |
12/21/2000 | CA2375998A1 Gene and protein sequences of phage t4 gene 35 |
12/21/2000 | CA2375386A1 Lipocalin family protein |
12/21/2000 | CA2374909A1 Human intracellular signaling molecules |
12/21/2000 | CA2374537A1 Method of high-concentration culture of nitrifying bacteria or denitrifying bacteria contained in activated sludge, culture promoter to be used in high-concentration culture method of nitrifying bacteria, and mehtod of weight loss treatment of activated sludge |
12/21/2000 | CA2373628A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
12/20/2000 | EP1060260A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor |
12/20/2000 | EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
12/20/2000 | EP1060255A2 Highly crystalline urokinase |
12/20/2000 | EP1060254A2 Human proteinase molecules |
12/20/2000 | EP1060253A2 Modified forms of pullulanase |
12/20/2000 | EP1060252A2 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity |
12/20/2000 | EP1060251A2 Phosphodiesterase 10 |
12/20/2000 | EP1060250A1 Modification of fatty acid metabolism in plants |
12/20/2000 | EP1060240A1 New agent |
12/20/2000 | CN1277636A High efficiency vetroviral rectors that contain none of viral coding sequences |
12/20/2000 | CN1277632A Natural human antibody |
12/20/2000 | CN1277631A Suspension packing cell lines for retrovirus vectors |
12/20/2000 | CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor |
12/20/2000 | CN1277258A Mutation alph-amylase |
12/20/2000 | CN1277207A Phytase with heat tolerance |
12/20/2000 | CN1277060A Production process of multielement glossy ganoderma selenium |
12/20/2000 | CN1059701C Donkey leukocyte hypotoxic strain for equine infection anemia and its culture method |
12/20/2000 | CN1059700C High-yield saltant aspergillus N1-14' for L-malic acid and method for producing L-malic acid |
12/19/2000 | US6162785 Polypeptide with amino acid sequence |
12/19/2000 | US6162640 Selected population of host cells and/or replicators which express a molecule that undergoes a desired interaction with a recognition sequence; for efficient and rational method of controlling evolution |
12/19/2000 | US6162636 Mutant cells of trigonopsis variabilis |
12/19/2000 | US6162633 Process and kit for fragment cloning |
12/19/2000 | US6162630 Asp1 |
12/19/2000 | US6162628 Enzymatic polypeptide which retards or prevents degradation/aging of baked goods |
12/19/2000 | US6162626 Thermostable glutamate dehydrogenase and process for producing the same |
12/19/2000 | US6162618 Nucleotide sequence; recombinant production; diagnosis of infections; drug screening; bactericides; bacteriostats; enzyme inhibitors; vaccines |
12/19/2000 | US6162617 Streptococcus pneumoniae gene sequence dnaG |
12/19/2000 | US6162612 Enzymatic polypeptide; for te detection of enzyme inhibitor which can be used to treat cancer, psoriasis and vascular system defects; anticarcinogenic agents |
12/19/2000 | US6162435 A isolated protein for treating swine; a diagnostic test kit for detecting the presence of bacterial infection in swine herds |
12/19/2000 | US6162429 Biologically pure serpens spp. strain hbl-112 (atcc 202005); treating infectious disease of the feet and/or lower legs of cattle |
12/19/2000 | CA2150232C A highly sensitive method for detecting environmental insults |
12/19/2000 | CA1341158C Octopine t-dna promoters |
12/14/2000 | WO2000075375A1 26 human secreted proteins |
12/14/2000 | WO2000075355A1 Novel process for producing l-epi-2-inosose and novel process for producing epi-inositol |
12/14/2000 | WO2000075350A2 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use |
12/14/2000 | WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof |
12/14/2000 | WO2000075347A2 Tet repressor-based transcriptional regulatory proteins |
12/14/2000 | WO2000075346A1 Fusion proteins comprising a fragment of a chaperon polypeptide |
12/14/2000 | WO2000075344A1 Pectate lyase fusion for expression and secretion of polypeptides |
12/14/2000 | WO2000075341A1 Δ6-acetylenase and δ6-desaturase from ceratodon purpureus |
12/14/2000 | WO2000075339A1 Substrate trapping protein tyrosine phosphatases |
12/14/2000 | WO2000075335A2 Bacteriophage rm 378 of a thermophilic host organism |
12/14/2000 | WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof |
12/14/2000 | WO2000075328A1 Human sel-10 polypeptides and polynucleotides that encode them |
12/14/2000 | WO2000075324A2 Recombinant prion-like genes and proteins and materials and methods comprising same |
12/14/2000 | WO2000075322A1 Insect monoamine transporter and methods of use thereof |
12/14/2000 | WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
12/14/2000 | WO2000075318A1 Phospholipid transfer protein |
12/14/2000 | WO2000075317A2 Compositions and methods for the treatment of tumor |
12/14/2000 | WO2000075315A1 Novel transporter gene expressed in liver |
12/14/2000 | WO2000075309A1 Spliceosome protein and its use |
12/14/2000 | WO2000075307A1 Hygromycin tolerance gene and transformed yeast belonging to the genus candida |
12/14/2000 | WO2000075305A2 Candida albicans genes and proteins coded by said genes |
12/14/2000 | WO2000075303A1 Primers for polymerase reactions |
12/14/2000 | WO2000075299A1 Hybrid yeast-bacteria cloning system and uses thereof |
12/14/2000 | WO2000075285A1 Selective media for recovery and enumeration of campylobacters |
12/14/2000 | WO2000075284A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use |
12/14/2000 | WO2000075283A1 Production by yeasts of aspartic proteinases from plant origin with sheep's, cow's, goat's milk, etc. clotting and proteolytic activity |
12/14/2000 | WO2000075282A1 Method for obtaining from a culture medium of microalgae, a heat-stable extract with antioxidant and wound healing activity |
12/14/2000 | WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof |
12/14/2000 | WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
12/14/2000 | WO2000075275A2 Bioreactor design and process for engineering tissue from cells |
12/14/2000 | WO2000075187A1 An integrin heterodimer and an alpha subunit thereof |
12/14/2000 | WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
12/14/2000 | WO2000075170A1 Mutant fatty acid desaturase and methods for directed mutagenesis |
12/14/2000 | WO2000075163A1 Angiogenic proteins and uses thereof |
12/14/2000 | WO2000075126A1 Mycolactone and related compounds, compositions and methods of use |
12/14/2000 | WO2000074722A2 Modification of biological elements |
12/14/2000 | WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
12/14/2000 | WO2000050612A3 Recombinant protein c activator and uses therefor |
12/14/2000 | WO2000049039A3 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
12/14/2000 | WO2000047758A3 Methods of making compounds |
12/14/2000 | WO2000042203A3 Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells |
12/14/2000 | DE19926770A1 Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen A nucleic acid fragment and vector containing a halogenase, and a process for the halogenation of chemical compounds |
12/14/2000 | CA2588221A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
12/14/2000 | CA2383828A1 26 human secreted proteins |
12/14/2000 | CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins |
12/14/2000 | CA2376629A1 Method for obtaining from a culture medium of microalgae, a heat-stable extract with antioxidant and wound healing activity |
12/14/2000 | CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
12/14/2000 | CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof |
12/14/2000 | CA2376189A1 Production by yeast cells of aspartic proteinases from plant origin with proteolytic activity |
12/14/2000 | CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
12/14/2000 | CA2376062A1 Fusion proteins comprising a fragment of a chaperon polypeptide |
12/14/2000 | CA2376055A1 Spliceosomal protein and its use |
12/14/2000 | CA2376053A1 Selective media for recovery and enumeration of campylobacters |
12/14/2000 | CA2376039A1 Bioreactor design and process for engineering tissue from cells |
12/14/2000 | CA2376018A1 Angiogenic proteins and uses thereof |
12/14/2000 | CA2376010A1 Mycolactone and related compounds, compositions and methods of use |
12/14/2000 | CA2375876A1 An integrin heterodimer and an alpha subunit thereof |
12/14/2000 | CA2375540A1 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use |
12/14/2000 | CA2375145A1 Substrate trapping protein tyrosine phosphatases |